The 2026 Nobel Prize in Physiology or Medicine has been jointly awarded to German and United States scientists for their groundbreaking work on optogenetics, a technique that has revolutionized the study and control of the brain. Karl Deisseroth of the United States, and Germans Peter Hegemann and Georg Nagel, were announced as the joint laureates on Monday. Their discoveries have provided researchers with an unprecedented tool for investigating how individual nerve cells and neural circuits control various functions.
The Nobel-winning work allows researchers to use light, combined with genetic modification, to switch selected brain cells on or off. This breakthrough has enabled scientists to study the brain with unprecedented precision, far surpassing traditional methods of manipulating brain activity. The technique has helped scientists investigate neurological and psychiatric disorders, including Parkinson’s disease, epilepsy, depression, addiction, dementia, and blindness.
At the heart of the breakthrough are light-sensitive proteins known as rhodopsins, which respond to light by controlling the movement of electrically charged particles across cell membranes. Through genetic engineering, scientists can introduce the genes responsible for these proteins into selected neurons, making them sensitive to light. Once the neurons have been modified, researchers can use pulses of light to turn them on or off and observe the resulting changes in brain activity and behavior.
The story behind the Nobel-winning discovery began with the study of microscopic organisms. Hegemann and Nagel investigated how single-celled algae respond to light, leading to the discovery and characterization of channelrhodopsin, a light-sensitive protein. This finding opened the possibility of making selected cells responsive to light through genetic modification, which researchers subsequently applied to nerve cells.
Deisseroth played a central role in developing the technique into a practical neuroscience tool, combining light-sensitive proteins with genetic techniques to control individual groups of neurons with flashes of light. The resulting method, known as optogenetics, has become one of the most important tools in modern neuroscience. It has helped scientists investigate neural circuits associated with various behaviors and offered new insights into how brain circuits become disrupted by disease.
Optogenetics has helped reveal how specific brain circuits are altered in conditions such as blindness, depression, addiction, and dementia. According to Abdel El Manira, a distinguished professor at the Karolinska Institutet and member of the Nobel Committee, the brain still holds countless mysteries, with optogenetics providing scientists with a powerful method for addressing them.
The significance of the Nobel-winning research extends beyond basic neuroscience, with scientists examining whether the ability to precisely control cells with light can be translated into treatments for neurological and sensory disorders. One promising area is retinitis pigmentosa, an inherited eye disorder in which light-sensitive cells in the retina gradually die, leading to progressive vision loss. Researchers are investigating whether genetic material encoding light-sensitive proteins can be delivered into surviving retinal cells to restore vision.
Key points
- The 2026 Nobel Prize in Physiology or Medicine was awarded to Karl Deisseroth, Peter Hegemann, and Georg Nagel for their pioneering work on optogenetics.
- Optogenetics has revolutionized the study and control of the brain, enabling researchers to use light to activate or silence specific cells.
- The technique has the potential to transform the treatment of neurological and sensory disorders, including retinitis pigmentosa and Parkinson’s disease.
